K G Smolderen

Saint Luke's Health System (KS, USA), Kansas City, KS, USA

Are you K G Smolderen?

Claim your profile

Publications (2)5.84 Total impact

  • Article: Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease.
    [show abstract] [hide abstract]
    ABSTRACT: To obtain Western European perspectives on the economic burden of atherothrombosis in patients with multiple risk factors only (MRF), cerebrovascular disease (CVD), coronary artery disease (CAD), and in the under-evaluated group of patients with peripheral arterial disease (PAD), we examined vascular-related hospitalisation rates and associated costs in France and Germany. The prospective REACH Registry enrolled 4693 patients in France, and 5594 patients in Germany (from December 2003 until June 2004). For each country, 2-year rates and costs associated with cardiovascular events and vascular-related hospitalisations were examined for patients with MRF, CVD, CAD, and PAD. Two-year hospitalisation costs were highest for patients with PAD (3182.1€ for France; 2724.4€ for Germany) and lowest for the MRF group (749.1€ for France; 503.3€ for Germany). Peripheral revascularizations and amputations were the greatest contributors to costs for all risk groups. Across all PAD subgroups, peripheral procedures constituted approximately half of the 2-year costs. Hospitalisation rates and costs associated with atherothrombotic disease in France and Germany are high, especially so for patients with PAD.
    European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery 02/2012; 43(2):198-207. · 2.92 Impact Factor
  • Source
    Article: Further validation of the peripheral artery questionnaire: results from a peripheral vascular surgery survey in the Netherlands.
    [show abstract] [hide abstract]
    ABSTRACT: Peripheral arterial disease (PAD) is associated with adverse cardiovascular events and can significantly impair patients' health status. Recently, marked methodological improvements in the measurement of PAD patients' health status have been made. The Peripheral Artery Questionnaire (PAQ) was specifically developed for this purpose. We validated a Dutch version of the PAQ in a large sample of PAD patients. Cross-sectional study. The Dutch PAQ was completed by 465 PAD patients (70% men, mean age 65+/-10 years) participating in the Euro Heart Survey Programme. Principal components analysis and reliability analyses were performed. Convergent validity was documented by comparing the PAQ with EQ-5D scales. Three factors were discerned; Physical Function, Perceived Disability, and Treatment Satisfaction (factor loadings between 0.50 and 0.90). Cronbach's alpha values were excellent (mean alpha=0.94). Shared variance of the PAQ domains with EQ-5D scales ranged from 3 to 50%. The Dutch PAQ proved to have good measurement qualities; assessment of Physical Function, Perceived Disability, and Treatment Satisfaction facilitates the monitoring of patients' perceived health in clinical research and practice. Measuring disease-specific health status in a reliable way becomes essential in times were a wide array of treatment options are available for PAD patients.
    European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery 10/2008; 36(5):582-91. · 2.92 Impact Factor

Institutions

  • 2012
    • Saint Luke's Health System (KS, USA)
      Kansas City, KS, USA
  • 2008
    • Tilburg Universiteit
      • CoRPS-Center of Research on Psychology in Somatic diseases
      Tilburg, North Brabant, Netherlands